Point-of-care troponin testing in patients with symptoms suggestive of acute coronary syndrome: a health technology assessment

Ho C, Cimon K, Weeks L, Mierzwinski-Urban M, Dunfield L, Soril L, Clement F, Jabr M
Record ID 32018002176
English
Authors' objectives: The aim of this health technology assessment (HTA) is to inform decision-making about the appropriate use of POC cardiac cTn testing. The policy question of whether to adopt POC troponin testing in specific settings (rural health care centres, remote locations, in hospital, in emergency settings) has been raised in Canadian jurisdictions. This HTA will address these questions by evaluating the diagnostic accuracy, clinical utility, and cost-effectiveness of POC cTn testing in patients presenting with ACS. The economic evaluation will determine the cost per quality-adjusted life-year (QALY) gained with POC troponin compared with central laboratory troponin testing (context 1) or no POC troponin testing (context 2).
Details
Project Status: Completed
URL for project: https://cadth.ca/point-care-troponin-testing-patients-symptoms-suggestive-acute-coronary-syndrome
URL for protocol: https://cadth.ca/sites/default/files/pdf/OP0519_PoC_Troponin_Protocol_June%202015.pdf
Year Published: 2016
URL for published report: https://cadth.ca/sites/default/files/pdf/OP0519_POC_Troponin_Report.pdf
URL for additional information: https://cadth.ca/point-care-troponin-testing-patients-symptoms-suggestive-acute-coronary-syndrome
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Canada
Pubmed ID: 27227213
MeSH Terms
  • Acute Coronary Syndrome
  • Troponin T
  • Point-of-Care Testing
  • Biomarkers
  • Costs and Cost Analysis
Keywords
  • Cardiac troponin testing
  • Point-of-care testing
  • Acute coronary syndrome
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: <p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.